The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics
Clinical trial NCT06534450 · UNKNOWN
Trial details
- NCT number
- NCT06534450
- Sponsor
- Dobri Kiprov
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2023-11-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.